API | aprocitentan

aprocitentan Report issue

Small molecule Experimental

AACT PubChem

Active Ingredient History

NOW

An era is a span of time defined for the purposes of chronology or historiography, as in the regnal eras in the history of a given monarchy, a calendar era used for a given calendar, or the geological eras defined for the history of Earth. ^Wikipedia

Chemistry

SMILES: NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1
InChIKey: DKULOVKANLVDEA-UHFFFAOYSA-N
Mol. Mass: 546.2
ALogP: 2.53 Partition coefficient
ChEMBL Molecule:
aprocitentan

More Chemistry

Pharmacology

Mechanisms of Action:
- Endothelin-1 receptor (Homo sapiens) ^UniProt
- Endothelin receptor type B (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

act-132577 | era

Organizations (3)

Research & Development (3)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (6)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (6)

Essential Hypertension (Phase 2)

Healthy Volunteers (Phase 1)

Hypertension (Phase 3)

Kidney Diseases (Phase 1)

Liver Diseases (Phase 1)

Renal Insufficiency, Chronic (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 12
# of Trial Organizations: 3

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue